3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Neoplasms
10
Breast Neoplasms
9
Ovarian Neoplasms
8
Prostatic Neoplasms
7
Multiple Myeloma
6
Hematologic Neoplasms
6
Lung Neoplasms
5
Depression
5
Sleep Initiation and Maintenance Disorders
4
Motor Activity
4
Fatigue
4
Breast Carcinoma In Situ
4
Anxiety Disorders
4
Leukemia
3
Fallopian Tube Neoplasms
3
Endometrial Neoplasms
3
Vulvar Neoplasms
2
Vaginal Neoplasms
2
Uterine Cervical Neoplasms
2
Sleep Wake Disorders
2
Pancreatic Neoplasms
2
Pain
2
Myelodysplastic Syndromes
2
Lymphoma, Non-Hodgkin
2
Leukemia, Myeloid
2
Leukemia, Lymphoid
2
Hodgkin Disease
2
Hematopoietic and Lymphoid System Neoplasm
2
Hematopoietic and Lymphatic System Neoplasm
2
Head and Neck Neoplasms
2
Interventions
Metformin
30
Exercise
8
Pioglitazone
7
Inositol
6
Insulin
4
Acupuncture Therapy
4
High-Intensity Interval Training
3
Ethinyl Estradiol
3
salicylsalicylic acid
2
drospirenone and ethinyl estradiol combination
2
Water
2
Tablets
2
Sugars
2
Resistance Training
2
Preoperative Exercise
2
Folic Acid
2
Diet Therapy
2
Cyproterone Acetate
2
Caloric Restriction
2
Biguanides
2
ziprasidone
1
maltodextrin
1
lime
1
licogliflozin
1
exendin (9-39)
1
drospirenone
1
cinnulin PF
1
adrenosterone
1
Zoledronic Acid
1
World Health Organization oral rehydration solution
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Insulin Resistance
×
Behavior Therapy
×
Clear all
NCT06545721
2025-12-03
WHIP
Peking Union Medical College Hospital
Phase NA
Recruiting
425 enrolled